Presentations/Abstracts

 

2018 

 

Does change in margin distance policy alter volume of tissue in breast conservation surgery?

Eur Society of Surg Oncology, Oct 2018, Budapest, Hungary

 

Rates of local recurrence following skin-sparing mastectomy for breast cancer

Does design of guide-wire influence re-excision rates in wire-guided breast conservation surgery?

Association of Breast Surgery, June 2018, Birmingham, UK

 

Two-year outcomes of immediate breast reconstruction in a University teaching hospital

European Breast Cancer Conference, March 2018, Spain

 

Assessment and patient selection in OncoPlastic and Reconstructive breast surgery

The Ideal Breast

Remit of Level 2 Oncoplastic Breast surgery

Perforator flaps Tips and Tricks

Implications of Radiotherapy on Oncoplastic outcomes

Therapeutic Mammoplasty: My approach

Invited Lectures & Live Oncoplastic Breast Surgery Workshop, March 2018, Egypt

 

Anatomy and Patient selection for Chest Wall flaps

Post-operative care and Follow-up for Chest Wall flaps

Case Discussions

Faculty, Oxford OncoPlastic Surgery Course, February 2018, Oxford, UK

 

Does size matter in selection for oncoplastic surgery in comparison with standard conservation

Use of a combination of modules of BREAST-QTM  in lateral chest wall flap breast reconstruction: a tale of two cities

Short-term outcomes of immediate breast reconstruction in a University teaching hospital

Neo-RT- Pre-operative breast IMRT with neo-adjuvant hormonal treatment for breast cancer - a feasibility study

Pioneer- Pre-operative window study of Letrozole plus Megestrol vs. Letrozole alone in ER+ breast cancer

UK interdisciplinary Breast Cancer Symposium, January 2018, Manchester, UK

 

2017

 

Anatomy and Patient selection for Chest Wall flaps

Post-operative care and Follow-up for Chest Wall flaps

Case Discussions

Introduction to Implant Breast Reconstruction

Director, Cambridge Flap Breast Reconstruction Course, November 2017, Cambridge, UK

 

Personalised Modern Breast Surgery: Oncoplastic Surgery adding Life to Life

Cancer Research UK (CRUK), Cambridge Centre, October 2017, UK

 

LiCAP flap reconstruction

North Breast Screening Surgeons Training Event, September 2017, Leeds, UK

 

Principles of Oncoplastic Breast Surgery

East of England Registrar Study Day, September 2017, Cambridge, UK

 

Implications on margin positivity rates following the introduction of an OncoPlastic service to a University hospital Breast Unit 

National meeting of Association of Breast Surgery (ABS), May 2017, Belfast, UK

 

Anatomy and Patient selection for Chest Wall flaps

Post-operative care and Follow-up for Chest Wall flaps

Case Discussions

Introduction to Implant Breast Reconstruction

Founder-Director-Faculty, Cambridge Flap Breast Reconstruction Course, April 2017, Cambridge, UK

 

Anatomy and Patient selection for Chest Wall flaps

Post-operative care and Follow-up for Chest Wall flaps

Case Discussions

Faculty, Oxford OncoPlastic Surgery Course, 17 March 2017, Oxford, UK  

 

Breast Reconstruction in Elderly Women  

Primary Breast Cancer in Older Women Symposium, 03 March 2017, Nottingham, UK

 

Chairperson: Endocrine therapy and Molecular targeted therapy

Level 2 OncoPlastic Breast-Conservation Surgery

Role of Breast Care Nurse in modern Breast Surgery

Therapeutic Mammoplasty - my approach

Bangla British Breast meeting, 18-19 February 2017, Kolkata, India

(Co-Founder & Overseas Advisor of BBB Group)

 

Basics of OncoPlastic and Reconstructive Breast Surgery

Association of Breast Surgery of India (ABSI) academic week, 14 Feb 2017, Lucknow, India

 

Trends in Reconstructive Breast Surgery at a UK Tertiary Centre pre and post-Acellular Dermal Matrices

Academic Surgical Congress, 07-09 February 2017, Las Vegas, USA

 

2016

 

Remit of OncoPlastic Breast Surgery

Assessment in OncoPlastic Breast Surgery

Chest wall flap as an alternative to LD flap

Annual International Academic meeting, October 2016, Hangzhou, China

 

Anatomy and Patient selection for Chest Wall flaps

Post-operative care and Follow-up for Chest Wall flaps

Case Discussions

Director, Cambridge Flap Breast Reconstruction Course, September 2016, Cambridge, UK  

 

OncoPlastic Breast Conserving Surgery - What the breast radiologist needs to know

http://bsbrevents.org/files/4214/7687/4177/PA.3.pdf

Annual Scientific meeting of British Society of Breast Radiologists, 06-08 November 2016, Manchester, UK

 

Reconstructive options for major excisions

Controversies in Clinical Oncology meeting, 23-24 July 2016, Kolkata, India  

 

Use of a combination of modules of BREAST-Q in partial breast reconstruction with lateral chest wall flap

National meeting of Association of Breast Surgery (ABS), May 2016, Manchester, UK

 

Neo-adjuvant chemotherapy, tumour biology and the degree of response – A Surgeon's perspective 

National meeting of Association of Breast Surgery (ABS), May 2016, Manchester, UK   

 

2015

 

A chart for rapid comprehensive assessment and planning for OncoPlastic and Reconstructive Breast Surgery

National meeting of Association of Breast Surgery (ABS), June 2015, Bournemouth, UK 

 

Remit of Modern OncoPlastic Breast Surgery

S Gupta Cancer Care and Research Centre, 02 July 2015, Thakurpukur-Kolkata, India

 

Implications of Adjuvant therapy on OncoPlastic Breast Surgery

National meeting of Asso. of Breast Surgeons of India, 26-28 June 2015, Indore, India

 

2014

 

Lateral chest wall perforator flap partial reconstruction of the breast following WLE

Chairperson: Sentinel Node Biopsy session

National meeting of Asso. of Breast Surgeons of India, 16-20 June 2014, Kolkata, India

 

Introduction of Enhanced Recovery After Surgery (ERAS) Pathways in LD Flap reconstruction

National meeting of Association of Breast Surgery (ABS), May 2014, Liverpool, UK 

 

Medium and long-term biological effects of fulvestrant on ER-positive human breast cancer

British Breast Group, 31 January 2014, York, UK

 

2013 and Prior Years 

 

Future trends in Breast Cancer Care

Derby Breast Cancer Patient Support Group, 05 September 2013, Derby, UK

 

Introduction of Enhanced Recovery After Surgery (ERAS) Pathways in LD Flap reconstruction

3rd ERAS UK Conference Proc, 08 November 2013, Birmingham, UK

 

Relevance of the rise in CA15.3 during fulvestrant therapy in advanced breast cancer patients

Meeting of American Society of Clinical Oncology, June 2013, Chicago, UK

 

Changing Trends in Consultant Practice and Breast Training in the United Kingdom

National meeting of Association of Breast Surgery (ABS), May 2013, Manchester, UK 

 

Recurrence rate after skin-sparing mastectomy and immediate reconstruction

National meeting of Association of Breast Surgery (ABS), May 2012, Bournemouth, UK 

 

Recurrence rate after skin-sparing mastectomy and immediate reconstruction: an update

European Breast Cancer Conference, March 2012, Vienna, Austria

 

Predictability of time to progression during fulvestrant treatment in breast cancer 

1st British Breast Cancer Research Conference Meeting Proc, Sept 2010, Nottingham, UK

 

Relation of tumour morphology with response during fulvestrant treatment in breast cancer

1st British Breast Cancer Research Conference Meeting Proc, Sept 2010, Nottingham, UK

 

Early therapeutic intervention based on blood tumour markers in patients with primary breast cancer 

1st British Breast Cancer Research Conference Meeting Proc, Sept 2010, Nottingham, UK

 

Long-term effect of fulvestrant on signalling elements in breast cancer

Meeting of the American Society of Clinical Oncology, June 2010, Chicago, USA

 

Early therapeutic intervention based on blood tumour markers (TMs) in patients with primary breast cancer

Meeting of the American Society of Clinical Oncology, June 2010, Chicago, USA

 

Long-term effect of fulvestrant on hormone receptors and proliferation marker in breast cancer

Nottingham International Breast Cancer meeting, September 2009, Nottingham, UK

 

Biological profile of oestrogen receptor α positive (ERα+) primary breast cancers in the elderly and their response to primary endocrine therapy  

Meeting of the American Society of Clinical Oncology, June 2009, Chicago, USA

 

Goserelin plus anastrozole (G+A) as first-line systemic therapy for premenopausal oestrogen receptor positive (ER+) advanced breast cancer (ABC) - clinical and endocrine data 

Meeting of the American Society of Clinical Oncology, June 2008, Chicago, USA

 

Clinical benefit as a surrogate marker of survival in patients receiving primary endocrine therapy in locally advanced primary breast cancer

Meeting of the American Society of Clinical Oncology, June 2008, Chicago, USA

 

Primary endocrine therapy in locally advanced breast cancers - Nottingham experience

Nottingham International Breast Cancer meeting, September 2007, Nottingham, UK

                                                              

Is the difference between tamoxifen and anastrozole in adjuvant trials applicable to primary endocrine therapy of early operable primary breast cancer in the elderly?  

Nottingham International Breast Cancer meeting, September 2007, Nottingham, UK

 

Anastrozole versus Tamoxifen as Primary Endocrine Therapy for Early Operable PrimaryBreast Cancer in the Elderly

Meeting of the American Society of Clinical Oncology, June 2007, Chicago, USA

 

Changes in HER-2 expression in sequential tumour biopsies while on fulvestrant for advanced breast cancer

San Antonio Breast Cancer Conference, December 2006, San Antonio, USA

 

Activity of fulvestrant in a subset of oestrogen receptor-positive patients with advanced breast cancer that overexpresses HER-2

San Antonio Breast Cancer Conference, December 2006, San Antonio, USA

 

Serum EGFR and HER-2 levels in metastatic breast cancer patients receiving Gefitinib therapy

San Antonio Breast Cancer Conference, December 2006, San Antonio, USA

 

Clinical relevance of “withdrawal therapy” from antiestrogens in breast cancer

British Association of Surgical Oncology, December 2006, London, UK

 

Can CT scan replace bone scan in detecting bone metastases from breast cancer? A prospective audit

British Association of Surgical Oncology, December 2006, London, UK

 

Oesophagogastric cancers secondary to a breast primary do not require resection

World Congress of the International Hepato-Pancreato-Biliary Association, 03-07 Sept 2006, Edinburgh, UK

 

Bone turnover markers in postmenopausal breast cancer patients treated with Fulvestrant

Meeting of the American Society of Clinical Oncology, June 2006, Atlanta, USA

 

CA15.3 and its correlation with clinical response in advanced breast cancer patients with Fulvestrant therapy  

Meeting of the American Society of Clinical Oncology, June 2006, Atlanta, USA

 

Primary endocrine therapy with anastrozole for early operable primary breast cancer in the elderly - early clinical and biological data  

Meeting of the American Society of Clinical Oncology, June 2006, Atlanta, USA

 

Biological characteristics of oestrogen receptor positive early operable primary breast cancer in the elderly

Meeting of the American Society of Clinical Oncology, June 2006, Atlanta, USA

 

Continued use of goserelin to achieve ovarian function suppression in combination with a further aromatase inhibitor (exemestane) following prior treatment with anastrozole and/or tamoxifen in premenopausal women with ER-positive advanced breast cancer

European Breast Cancer meeting, March 2006, Nice, France

 

Clinical experience with Fulvestrant: The Nottingham experience in postmenopausal women with advanced breast cancer

European Breast Cancer meeting, March 2006, Nice, France

 

Efficacy and tolerability of gefitinib in oestrogen receptor negative and tamoxifen resistant oestrogen receptor positive locally advanced or metastatic breast cancer

San Antonio International Breast Cancer Conference, December 2005, San Antonio, USA

 

Response to further endocrine therapies following de novo or acquired resistance to first-line endocrine therapy for advanced breast cancer 

Nottingham International Breast Cancer meeting, September 2005, Nottingham, UK

 

High dose oestrogen (HDE) as an endocrine therapy option for advanced breast cancer 

Nottingham International Breast Cancer meeting, September 2005, Nottingham, UK

 

Private Contact

 

E-mail

cambridge.breast@gmail.com

 

Or use our contact form.

 

 

Spire Lea Cambridge Hospital,

30 New Road, Impington,

Cambridge, CB24 9EL

Amit Agrawal

 

Nuffield Cambridge Hospital,

4 Trumpington Road,

Cambridge, CB2 8AF

Amit Agrawal

 

BUPA

Amit Agrawal

 

NHS

 

Addenbrooke's Hospital

Box 97, Cambridge Breast Unit,

Cambridge, CB2 0QQ

Amit Agrawal

 

Secretary: Karrie

Phone: +44(0)1223 216 315

 

Get social with us.

Print Print | Sitemap
© AMIT AGRAWAL

Call

E-mail